{"transactions":[{"id":3230525,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":151063,"kind":"person","name":"ESTES DANIEL","position":1,"cik":"0001702527","reported_name":"ESTES DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T20:59:31.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable 100% on the earlier of the date of the next annual meeting of the Issuer's stockholders or February 27, 2021."}],"balance_after":24000,"derivative":{"exercise_price":27.61,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001567619-20-005544","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702527/000156761920005544/doc1.xml","form_type":"4"}},{"id":3492526,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":151063,"kind":"person","name":"ESTES DANIEL","position":1,"cik":"0001702527","reported_name":"ESTES DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T17:48:58.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 11, 2019, with 100% of the total shares vested and exercisable on June 11, 2020, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.66,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-036485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919119036485/doc4.xml","form_type":"4"}},{"id":3893645,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":151063,"kind":"person","name":"ESTES DANIEL","position":1,"cik":"0001702527","reported_name":"ESTES DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T17:15:22.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 8.333% of the total shares monthly, beginning on July 12, 2018, with 100% of the total shares vested and exercisable on June 12, 2019, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.27,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-037795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919118037795/doc4.xml","form_type":"4"}},{"id":4301112,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":151063,"kind":"person","name":"ESTES DANIEL","position":1,"cik":"0001702527","reported_name":"ESTES DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-30T16:44:45.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on April 10, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 8.333% of the total shares monthly, beginning on June 25, 2017, with 100% of the total shares vested and exercisable on May 25, 2018, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":1.2,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-036145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919117036145/doc4.xml","form_type":"4"}}]}